MDAI

News

globenewswire.comSpectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Monthglobenewswire.comJun 12

globenewswire.comSpectral AI to Participate in 2026 British Burn Association Annual Conferenceglobenewswire.comJun 11

globenewswire.comSpectral AI Announces Voting Results of Annual Meeting of Stockholdersglobenewswire.comJun 1

globenewswire.comSpectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indicationglobenewswire.comMay 26

marketbeat.comSpectral AI Q1 Earnings Call Highlightsmarketbeat.comMay 12

Trade MDAI

About Spectral AI, Inc.

Spectral AI, Inc. is an artificial intelligence (AI) firm specializing in AI-driven medical diagnostics. The company's primary goal is to facilitate faster and more accurate treatment decisions in wound care, particularly for patients dealing with burns and diabetic foot ulcers. Among its key products is DeepView, a predictive diagnostic device that delivers an objective and immediate evaluation of a wound's likely healing trajectory to clinicians, prior to any medical treatment or intervention. Spectral AI, Inc. is headquartered in Dallas, Texas.

CEO: Vincent Stanley Capone
IPO Date: Apr 6, 2021

Market Data

Open: $1.85
High: $1.85
Low: $1.74
Volume: 492.1K
Avg Volume: 777.4K
52W High: $3.21
52W Low: $1.18

Valuation

Market Cap: $58M
Enterprise Value: $56M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-9.9M
Revenue: $20M
Net Income: $-7.6M
Cash: $15M
Debt: $10M

Events

EarningsAug 11

EPS est. -0.14